Emerging Therapies for Critical Limb Ischemia

Emerging therapies for critical limb ischemia (CLI) aim to improve outcomes and prevent amputations in patients with severe arterial insufficiency. Innovative approaches, including stem cell therapy, gene therapy, and enhanced endovascular techniques, are being explored to promote revascularization and tissue regeneration. The use of novel devices such as drug-coated balloons and bioengineered grafts has shown promise in addressing complex lesions. Multidisciplinary care, integrating medical and surgical management, is essential for optimizing treatment strategies. As research progresses, these emerging therapies may significantly impact the clinical management of CLI, offering hope for affected patients.

    Related Conference of Emerging Therapies for Critical Limb Ischemia

    May 21-22, 2026

    15th World Congress on Cardiology

    London, UK
    June 15-16, 2026

    7th European Summit on Cardiology Research

    Zurich, Switzerland
    July 27-28, 2026

    12th International Heart Conference

    Dubai, UAE
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France
    August 17-18, 2026

    4th International Conference on World Heart Care

    Toronto, Canada
    August 24-25, 2026

    15th World Heart Congress

    London, UK
    August 27-28, 2026

    40th European Cardiology Conference

    Berlin, Germany
    November 09-10, 2026

    7th Annual Summit on Cardiology and Heart Diseases

    Paris, France
    November 16-17, 2026

    8th World Heart Congress

    Tokyo, Japan
    November 23-24, 2026

    40th World Congress on Heart Diseases

    Toronto, Canada
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France
    March 18-19, 2027

    16th World Heart Congress

    Paris, France

    Emerging Therapies for Critical Limb Ischemia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in